Perspectives; Thoughts; Comments; Opinions; Discussions

Posts tagged ‘vaccine’

20 million Americans could receive Covid-19 vaccine in December


Reported by SARAH OWERMOHLE | Politico | November 16, 2020

Roughly 20 million people could be vaccinated against the coronavirus in December, the head of the Trump administration’s vaccine and drug accelerator said Friday. Americans can expect that about 25 to 30 million people could be vaccinated each month afterward, said Moncef Slaoui, co-lead of Operation Warp Speed, during a Rose Garden event with President Donald Trump and other top health officials.

That timeline depends on the Food and Drug Administration authorizing the emergency use of one or more vaccines — which could happen in a matter of weeks, Slaoui noted.

Pfizer announced promising data this week suggesting its vaccine is more than 90 percent effective, and has said it will apply to FDA later this month. Moderna, which is working closely with the National Institutes of Health, is preparing to announce its own efficacy data in a matter of days. An emergency-use application could soon follow, Slaoui said.

Gen. Gustave Perna, Operation Warp Speed’s chief operating officer, said that the government would begin vaccination within 24 hours after a shot secures emergency authorization.

But while manufacturers have developed coronavirus vaccines in record speed, and dozens more are still in the pipeline, Slaoui’s projections mean it will likely take months just for first-priority groups such as health care workers and the elderly to get a shot.

Both the Pfizer and Moderna vaccines are given as two doses, effectively cutting in half the government’s initial order of 100 million doses from each of the those manufacturers.

But Slaoui added that there could be more authorized vaccines in the spring, boosting chances for more people to get vaccinated. Four vaccines, including the Pfizer and Moderna shots, are now in late-stage U.S. trials, and at least one other company plans to start such a study this month.

“We may be able to immunize a larger number of Americans on an ongoing basis, per month,” Slaoui said after name-checking other promising candidates from AstraZeneca and Johnson & Johnson.

The government has not yet released a comprehensive plan to distribute any coronavirus vaccines, including how it will handle logistics for shots that need to be shipped in below-freezing temperatures and outreach to skeptical communities.

Because of the real-world challenges of vaccine distribution and supply, federal health officials including CDC Director Robert Redfield project that broad access will not be a possibility until summer 2021.

BREAKING: Pfizer’s COVID vaccine 90 percent successful in trials


Reported by Leonardo Briceno, The Post Millennial |

Read more at https://www.conservativereview.com/breaking-pfizers-covid-vaccine-90-percent-successful-in-trials-2648793873.html/

A COVID-19 vaccine developed by Pfizer Incorporated and BioNTech SE has been found to be more than 90 percent successful in large-scale trails against the coronavirus. In a press release made by Pfizer, the development team announced that their vaccine candidate had successfully deterred the spread of COVID-19 in thousands of trials and was now being submitted before the United States Food and Drug Administration for Emergency Use Authorization. Per the release, of the 43,000 test subjects, only 94 returned with positive COVID-19 cases—less than a percent of participants.

The Trump administration had made a deal in June with Pfizer to ensure that the vaccine would be made free to 100 million Americans, upon successful development.

Dr. Albert Bourla, CEO and Chairman of Pfizer, said that their breakthrough represented the beginning of a new chapter in the fight against COVID-19.

“We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen,” Bourla said.

President Donald Trump took to Twitter to share the good news. In the weeks leading up to election night, the president stressed that the development of a vaccine would provide the confidence the country would need to re-open safely.

For investors and businesses anxiously awaiting news of a vaccine, Pfizer’s test results are a vote of confidence in the future.

Where Pfizer and BioNTech may now be at the frontrunners of those developing a vaccine, they aren’t the only ones in the homestretch of vaccine development. The University of Oxford in association with AstraZeneca is currently in the middle of human trials in Brazil. Johnson and Johnson and GlaxoSmithKline trail the frontrunners only by a month or so. All of these development teams plan to have a releasable product by February.

If approved by the FDA, Pfizer and BioNTech will be set up to release a product before then.

Already, news for the development of a vaccine has reached Wall Street, causing an immediate jump in the DOW.

Like many who continue to look forward to a vaccine deployment, Bourla believes the introduction of a vaccine will directly impact an ability for communities around the world to return to normalcy.

“With today’s news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis. We look forward to sharing additional efficacy and safety data generated from thousands of participants in the coming weeks,” Bourla said.

Tag Cloud

%d bloggers like this: